Drug candidate shields gut to treat severe fatty liver in animal models
A glycine-based tripeptide named DT-109 has demonstrated a striking ability to reverse severe fatty liver disease in animal models by ...
A glycine-based tripeptide named DT-109 has demonstrated a striking ability to reverse severe fatty liver disease in animal models by ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine